Skip to main content

Advertisement

SpringerLink
Log in

The effect of ramipril versus amlodipine on renal outcomes in hypertensive nephrosclerosis

  • Clinical Trials Report
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Voyaki SM, Staessen JA, Thijs L, et al.: Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. J Hypertens 2001, 19:511–519.

    Article  PubMed  CAS  Google Scholar 

  2. Materson BJ, Reda DJ, Cushman WC, et al.: Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents: Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993, 328:914–921. [Published correction appears in N Engl J Med 1994, 330:1689].

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Donald G. Vidt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vidt, D.G. The effect of ramipril versus amlodipine on renal outcomes in hypertensive nephrosclerosis. Current Science Inc 3, 379–380 (2001). https://doi.org/10.1007/s11906-001-0053-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-001-0053-3

Keywords

Search

Navigation